New York, NY, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Injectable Drug Delivery Market by Type (Formulation and Devices), by Application (Autoimmune Diseases, Oncology Disorders, Hormonal Disorders, Orphan Diseases, and Others), and by End-User (Hospital, Home Care, Ambulatory Care, Physician Offices or Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” . According to the report, the global injectable drug delivery market was USD 444 million in 2018 and is expected to generate around USD 932 million by 2025, at a CAGR of 11.2% between 2019 and 2025.
The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc., and technological innovations related to advanced device development in injectable drug delivery systems According to the RAND Corporation, about 60% of Americans live with at least one chronic disease and about 42% are suffering from more than chronic disease. The various technological developments have resulted in the growth of innovative devices that are specially developed according to the specific patient care category.
Browse through 70 Tables & 24 Figures spread over 120 Pages and in-depth TOC on “Global Injectable Drug Delivery Market: By Type, Devices, Size, Share, Applications, Trends, Analysis and Forecast 2018–2025”.
Request Free Sample Report of Global Injectable Drug Delivery Market Report @ https://www.zionmarketresearch.com/sample/inj...ery-market
Furthermore, the introduction of dual-injectable devices has further improved the method of injectable drug delivery. However, in the healthcare sector, the lack of awareness regarding contaminations and injuries caused by the use of needles in syringes might hinder the growth of the global injectable drug delivery market in the upcoming years. According to the WHO (World Health Organization), every year more than 2 million needlestick injuries are recorded globally. The continuous growth in the number of infections and injuries caused by needles in the past few years has led to patient hesitancy to use injections, which might also obstruct the growth of the injectable drug delivery market globally over the estimated timeframe. Nevertheless, the increasing demand for generic injectable and biosimilar is anticipated to generate new growth opportunities in the future for the injectable drug delivery market.
The global injectable drug delivery market is fragmented into type, application, and end-user. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. In terms of market share, the formulation segment held the largest share in the global injectable drug delivery market in 2018, owing to its high efficiency and minimal size.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbro...ery-market
By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. Hormone disorders held the largest share of the global injectable drug delivery market in 2018, due to the growing prevalence of hormonal disorders, such as diabetes. By end-user, the global market includes home care, hospital, ambulatory care, physician offices or clinics, and others. The home care segment held the largest share of this market, due to the high use of self-injectable pens and other devices at home majorly by diabetic patients.
By region, North America dominated the global injectable drug delivery market in 2018 and is expected to remain dominant over the forecast time period as well. This can be attributed to the rising incidences of diabetes and a growing aging population. According to the American Diabetes Association, more than 450 million people in the world and about 30 million people in the U.S. suffer from diabetes. Moreover, the increasing adoption of technically advanced drug delivery systems is anticipated to further boost the growth of this regional market. For instance, the next generation of injectable drug delivery systems offers a wide range of innovative upgrades, such as self-administered injectable with limiting dose user-friendly wearables designed to professional systems for immediate mix and delivery of multifarious components allows least fluctuations in the concentration of pharmaceutical ingredient throughout the injection like dual release formulations. The high acceptance and awareness about various drug delivery system innovations in North America are likely to significantly contribute toward the growth of this regional market in the future.
Request for Discount: https://www.zionmarketresearch.com/requestdis...ery-market
Europe held the second position in terms of market share in the global injectable drug delivery market in 2018.
In the global injectable drug delivery market, the Asia Pacific region is anticipated to witness the highest CAGR over the forecast time period. India and China held the largest shares of the Asia Pacific injectable drug delivery market in 2018. The large population base in China and India and the high patient pool of chronic disease likely to contribute toward the growth of this regional market over the forecast time period. Moreover, the increasing healthcare expenditure, growing healthcare awareness, and rising investments made by various key players operating in the region for the development of newer injectable drug delivery technology are some other prominent factors anticipated to boost this regional market’s growth in the upcoming years.
Browse the full “Injectable Drug Delivery Market by Type (Formulation and Devices), by Application (Autoimmune Diseases, Oncology Disorders, Hormonal Disorders, Orphan Diseases, and Others), and by End-User (Hospital, Home Care, Ambulatory Care, Physician Offices or Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/inj...ery-market
Latin American and the Middle Eastern and African regions held the lowest shares of the global injectable drug delivery market in 2018. This can be due to low awareness among the people about new technologies and lower affordability rates.
Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/in...ery-market
This report segments the global injectable drug delivery market into:
Global Injectable Drug Delivery Market: Type Analysis
- Formulation
- Conventional Drug Delivery
- Suspensions
- Solutions
- Lyophilized Formulations
- Emulsions
- Novel Drug Delivery
- Long Acting Injection Formulation
- Microparticles
- Colloidal Dispersions
- Others
- Conventional Drug Delivery
- Devices
- Self-Injection Devices
- Needle-Free Injectors (NFI)
- Wearable Injectors
- Pen Injectors
- Auto-Injectors
- Others
- Conventional Injection Devices
- Prefilled Syringes
- Fillable Syringes
- Others
- Self-Injection Devices
Global Injectable Drug Delivery Market: Application Analysis
- Autoimmune Diseases
- Oncology Disorders
- Hormonal Disorders
- Orphan Diseases
- Others
Global Injectable Drug Delivery Market: End-User Analysis
- Home Care
- Hospital
- Ambulatory Care
- Physician Offices or Clinics
- Others
Global Injectable Drug Delivery Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Central Venous Catheters Market: https://www.zionmarketresearch.com/report/cen...ers-market
- Ophthalmic Viscosurgical Devices Market: https://www.zionmarketresearch.com/report/oph...ces-market
- Dental Imaging System Market: https://www.zionmarketresearch.com/report/den...tem-market
- Cardiovascular Devices Market: https://www.zionmarketresearch.com/report/car...ces-market
- Surgical Apparel Market: https://www.zionmarketresearch.com/report/sur...rel-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research
Blog: http://zmrindustryjournal.us | http://zmrresearchnews.us | http://zmrmarketjournal.com
Contact Us:
Joel John 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com
